Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ELVN
#1718
Enliven Therapeutics, Inc. Common Stock
29.690
0
+2.63%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+2.63%
Aylık değişim
+13.58%
6 aylık değişim
+43.71%
Yıllık değişim
+43.71%
Önceki kapanış
28.930
0
Open
29.700
0
Bid
Ask
Low
29.690
0
High
29.700
0
Hacim
140
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
ELVN
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
17.58 M
26.29 M
26.23 M
41.35 M
49 M
—
Valuation ratios
Enterprise value
—
—
—
515.94 M
978.48 M
4.02 B
Price to earnings ratio
—
—
—
-7.41
-11.9
-43.31
Price to sales ratio
—
—
—
—
96.28 K
—
Price to cash flow ratio
—
—
—
8.64
14.47
56.17
Price to book ratio
—
—
—
2.15
3.42
5.64
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.46
0.55
0.02
0.26
0.27
0.26
Return on equity %
0.49
0.6
0.02
0.29
0.29
0.27
Return on invested capital %
51.61 K
33.32 K
156.69
2 319.69
1 935.13
2 536.97
Gross margin %
—
—
100
—
100
—
Operating margin %
—
—
4 562.5
—
950.49 K
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
9 300
—
809.31 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
14.47
12.86
48.98
10.28
19.99
106.58
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
0
—
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
1.35
1.72
1.55
1.39
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
3.34
7.12
6.66
29.55
Net current asset value per share
—
—
3.4
7.49
6.76
29.92
Tangible book value per share
—
—
3.42
6.92
6.58
29.38
Working capital per share
—
—
3.33
6.76
6.42
28.78
Book value per share
—
—
3.42
6.92
6.58
29.38
Haberler
Heyman, Enliven Therapeutics director, sells $32k in stock
Lyssikatos, Enliven Therapeutics CSO’su, 145 bin dolarlık hisse satışı gerçekleştirdi
Lyssikatos, Enliven Therapeutics CSO, sells $145k in shares
Lyssikatos, Enliven Therapeutics CSO, sells $535k in ELVN stock
Enliven Therapeutics yöneticisi Heyman 32.901 dolarlık hisse satışı gerçekleştirdi
Enliven Therapeutics director Heyman sells $32,901 in stock
Anish Patel, COO of Enliven Therapeutics, sells $1.35m in ELVN
Enliven Therapeutics: Springing Into 2026 With Data, But I'm Still Cautious
Enliven Therapeutics CSO’su Lyssikatos 3,47 milyon dolarlık hisse satışı gerçekleştirdi
Enliven Therapeutics CSO Lyssikatos sells $3.47 million in shares
Enliven Therapeutics hisseleri 25,64 dolar ile 52 haftalık zirveyi gördü
Enliven Therapeutics stock hits 52-week high at $25.64